Dr. Mantra, a pioneering wellness startup following a direct-to-consumer (D2C) model and rooted in Ayurvedic principles, has successfully secured a bridge round of funding amounting to nearly $200K. This funding effort was led by 100X and saw the participation of esteemed angel investors, including Deep Bajaj and Mohit Bajaj, the founders of the renowned FemTech brand, Sirona.
Headquartered in Mahuwa, Gujarat, the startup envisions utilizing the freshly acquired funds to drive its business growth strategy, with the ultimate goal of doubling its operational scope before embarking on a series A funding round.
Founded in 2021 by the dynamic duo of Takki Zain and Shivansh Jain, Dr. Mantra presents a comprehensive range of Ayurvedic-based treatments catering to individuals grappling with lifestyle-related ailments such as kidney stones, piles, obesity, sexual wellness issues, and PCOS. The startup adopts a scientific approach, incorporating Ayurvedic products, personalized diet plans, and expert medical support, all contributing to a holistic healing process. Notably, the startup’s website emphasizes its remarkable offering of “60% faster treatment with personalized Ayurvedic methodology, boasting a 93% success rate.”
In a recent LinkedIn post, Takki Zain, Co-founder of Dr. Mantra, shared the company’s remarkable journey, stating, “After receiving the backing of 100X.VC in January 2023, we experienced a threefold surge in revenue within a mere six months, propelling us to a positive unit economics with a Monthly Recurring Revenue (MRR) of 60 Lakhs. This outstanding achievement caught the attention of Deep Bajaj.”
Dr. Mantra’s innovative and holistic approach to wellness, combined with its strategic funding efforts, positions the startup as a frontrunner in the realm of Ayurved-based wellness, ready to further expand its impact and reach.